Goflikicept
Based on 1 Customer Validation
Goflikicept (RPH 104) is a fusion protein that selectively binds and inactivates both circulating IL-1β and IL-1α. Goflikicept has the potential for the research of ST-segment elevation myocardial infarction (STEMI).
연구목적의 판매만을 진행합니다. 환자를 대상으로 한 판매는 하지 않습니다.
- Purity: 98.32%
- CAS No.: 2416984-26-2
- 분자량:126.22 kDa
-
보관:
Please store the product under the recommended conditions in the Certificate of Analysis.
Biological Activity
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
| NCT Number | Sponsor | Condition | Start Date |
Phase
|
|---|---|---|---|---|
| NCT01329991 | Plexxikon| | 2011-05 | PHASE1 |
Unconjugated
The product can be reconstituted/diluted with sterile PBS or saline.
-
IL1RAP (interleukin-1 receptor accessory protein)fragment 21-358-IGHG1 Fc (Fragment constant)-covalent dimer-IL1R1 (type 1 interleukin-1 receptor, interleukin 1 receptor, type I)fragment 21-333-IGHG1 Fc (Fragment constant)
ELISA, FACS, Functional assay
Chemical Information
-
CAS No. 2416984-26-2
-
Appearance Liquid
-
분자량 126.22 kDa
-
Color Colorless to light yellow
-
SMILES
[Goflikicept]
-
Synonyms
RPH 104
-
선적
Shipping with dry ice.
-
Formulation
Please refer to the lot-specific COA for specific buffer information.
-
보관
Please store the product under the recommended conditions in the Certificate of Analysis.
순도&문서
-
Data Sheet (255 KB)
-
SDS (251 KB)
- English - EN (251 KB)
- Français - FR (251 KB)
- Deutsch - DE (251 KB)
- Norwegian - NO (251 KB)
- Español - ES (251 KB)
- Swedish - SV (251 KB)
- Italian - IT (251 KB)
- Korean - KR (251 KB)
- Portuguese - PT (251 KB)
-
Inhibitory Antibodies User Guide (603 KB)
References
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)